Akari Therapeutics Plc (AKTX) Slipped -5.77% or -0.18 To Price $2.94 On Wednesday

Akari Therapeutics Plc (AKTX) slipped -5.77% or -0.18 to $2.94. It is around 132138 shares traded, which is 12.07% compare to the average total volume 1.09 million. The market cap of AKTX is $46.62 million. The year to date change is 81.62%. The 52 week price range is from $1.56 to $9.2. Price of AKTX have changed -7.14% during last week. It have changed -1.58% over last month, 64.21% over last 3 months, 71.43% over last 6 months and 61.66% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKTX is 3.43. It is 16.67% above current price. The 200-day Moving Averages for AKTX is 2.28. It is -22.45% below current price. The 52-week High is 9.2. It is 212.93% from the current price. The 52-week Low is 1.56. It is -46.94% from current price.

There are some statistics of AKTX. It is has market cap $46.62 million. The share outstanding is 15.86 million. The average volume is 1.09 million. The percent of top 15 Institution holding is 13.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKTX is -168.61%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKTX is -91.90%.


Share this post